GlassScriptPhysician profile
Bora A Duruman
NPI 1235163213
$281.34
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.20 · 2020: $64.65 · 2022: $51.84 · 2023: $91.20 · 2024: $61.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $101.97 | 2023-2024 | |
| Abbvie INC. | $48.31 | 2019-2023 | Ubrelvy |
| Organon LLC | $30.79 | 2022 | |
| Merck Sharp & Dohme LLC | $29.21 | 2020 | |
| Hologic Sales and Service, LLC | $21.05 | 2022 | |
| Astellas Pharma US INC | $19.29 | 2023 | Veozah |
| Avion Pharmaceuticals | $16.68 | 2023 | Balcoltra |
| Minerva Surgical, INC | $14.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bora Duruman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.